Seven Eight Capital’s Globus Medical GMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-4,702
Closed -$336K 255
2024
Q3
$336K Buy
+4,702
New +$332K 0.03% 627
2021
Q4
Sell
-18,322
Closed -$1.4M 549
2021
Q3
$1.4M Buy
18,322
+3,900
+27% +$313K 0.14% 239
2021
Q2
$1.12M Buy
+14,422
New +$1.03M 0.16% 226
2020
Q4
Sell
-9,722
Closed -$481K 495
2020
Q3
$481K Buy
+9,722
New +$501K 0.1% 349
2020
Q1
Sell
-14,714
Closed -$866K 550
2019
Q4
$866K Buy
+14,714
New +$799K 0.05% 470

Other funds holding GMED

Seven Eight Capital's GMED Position: Q4 2024 in Review

Seven Eight Capital sold out of Globus Medical (GMED) in Q4 2024, closing a stake of 4,702 shares — an estimated $336K sold.

Seven Eight Capital first reported a position in GMED in Q4 2019 and held it in 5 quarters. The position peaked at $1.4M in Q3 2021. 500 funds tracked by Wall St. Rank hold GMED as of Q4 2024.

  • Seven Eight Capital reported no remaining Globus Medical position as of Q4 2024 after selling out during the quarter.
  • Seven Eight Capital sold 4,702 Globus Medical shares in Q4 2024, an estimated $336K.
  • Seven Eight Capital first reported a position in Globus Medical in Q4 2019 and held it in 5 quarters.
  • Seven Eight Capital's Globus Medical position peaked at $1.4M in Q3 2021.
  • 500 funds tracked by Wall St. Rank held Globus Medical as of Q4 2024.

Based on Seven Eight Capital's 13F filing for Q4 2024.